Page last updated: 2024-11-05

zm 336372 and Pheochromocytoma

zm 336372 has been researched along with Pheochromocytoma in 1 studies

N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide: an inhibitor of c-Raf; activates Raf-1; structure in first source

Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kappes, A1
Vaccaro, A1
Kunnimalaiyaan, M1
Chen, H1

Other Studies

1 other study available for zm 336372 and Pheochromocytoma

ArticleYear
ZM336372, a Raf-1 activator, inhibits growth of pheochromocytoma cells.
    The Journal of surgical research, 2006, Jun-01, Volume: 133, Issue:1

    Topics: Animals; Benzamides; Cell Proliferation; Chromogranin A; Chromogranins; MAP Kinase Signaling System;

2006